Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

(MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic treatment, this weekend here at the American Heart Association (AHA) annual meeting.
Spearheading…